Prescribing and deprescribing antihypertensive medication in older people by Dutch general practitioners: a qualitative study

Abstract

ObjectivesTo explore general practitioners’ (GPs) routines and considerations on (de)prescribing antihypertensive medication (AHM) in older patients, their judgement on usability of the current guideline and needs for future support.DesignSemistructured interviews.SettingDutch general practice.ParticipantsFifteen GPs were purposively sampled based on level of experience and practice characteristics until saturation was reached.ResultsGPs appeared reluctant to start AHM, especially in patient >80 years. High systolic blood pressure and history of cardiovascular disease or diabetes were enablers to start or intensify treatment. Reasons to refrain from this were frailty and patient preference. GPs described a tendency to continue AHM regimens unchanged, influenced by daily time constraints, automated prescription routines and anticipating discomfort when disturbing patients’ delicate balance. GPs were only inclined to deprescribe AHM in terminally ill patients or after prolonged achievement of target levels in combination with side effects or patient preference. Deprescription was facilitated when GPs had experience with patients showing increased quality of life after deprescription and was withheld by anticipated regret (ie, GPs’ fear of a stroke after deprescribing). GPs felt insufficient guidance from current guidelines, especially on deprescription.ConclusionsGPs are reluctant to start or deprescribe AHM in older people and have a propensity to continue AHM within a daily routine that insufficiently supports critical medication review. (De)prescription is influenced by patient preferences and anticipated regret and current guidelines provide insufficient guidance.

Prescription patterns of lipid lowering agents among older patients in general practice: an analysis from a national database in the Netherlands

“…Frail older adults are more likely to have a limited life expectancy, and to experience drug-drug interactions and/or unwanted drug side effects [13]. Also, they are more likely to die from non-CVD, i.e.…”

Hypertension and Drug Adherence in the Elderly

“…Thus, withdrawing antihypertensive drug therapies in elderly might not always be innocent depending on the level of cardiovascular risk of the patient. The fear of an event is one reason why physicians are often reluctant and uncomfortable changing antihypertensive medications even in advanced age (91).…”

Exploring how GPs discuss statin deprescribing with older people: a qualitative study

“…Uncertainty was also seen as being difficult to discuss. GPs in Australia, 14 the Netherlands, 31 and New Zealand 16 have also noted that uncertainty makes deprescribing decisions difficult. However, awareness and discussion of such topics is likely an important component of a shared decision surrounding deprescribing statins, given the current evidence base.…”